Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Covance, Inc.

Product Description

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

Nonclinical Development: Toxicology, Research Products, Analytical Services

• Managed 443 compound development programs (>250 IND/CTA enabling), with  over 100 different sponsors, which led to 41 IND/CTA applications in 2009
• Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks
• Dedicated Capacity Agreements with several major pharma customers
• Greater than 2.5M sq ft of research space

Clinical Development: Clinical Pharmacology, Clinical, Central Labs

• Supported 50% of latest breakthrough cancer treatments
• Supported development of the top 25 currently marketed medicines
• 70% of clinical programs on or ahead of enrollment timelines
• Broad-based, scalable and market-leading, Biomarker capability
• 99% of samples received within stability
• 145 million laboratory tests; 83,000 investigator sites; 100 countries
• Seven Clinical Pharmacology units with ~500 beds

Periapproval & Market Access

• Results-driven reimbursement support for >60% of the biologics market
• Designed and managed world’s largest safety registry ever – iPledge
• Team of experts dedicated to risk management and Pharmacovigilance
• Bi-coastal call center capabilities to deliver patient and physician support
Product Covance, Inc.
Company Covance - Service Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Covance - Service Directory
210 Carnegie Center Princeton, New Jersey 08540 United States

Tel: +1.888.268.2623



Scientific News
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
Teeth Reveal Lifetime Exposures to Metals, Toxins
Researchers have identified dental biomarkers to reveal links between early iron exposure and late life brain diseases.
An Innovative Algorithm to Decipher How Drugs Work Inside the Body
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
Uncovering the Spread of Bacteria in Pneumonia
Northwestern Medicine scientists have discovered the role a toxin produced by a pneumonia-causing bacterium plays in the spread of infection from the lungs to the bloodstream in hospitalized patients.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!